Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man.

Abstract 1 Dose-dependent increments of plasma noradrenaline were observed during graded infusions of (±)isoprenaline (3.5-35 ng kg-1 min-1 i.v.) in seven normal subjects and in ten subjects with borderline hypertension. At the highest dose of isoprenaline, noradrenaline rose by 166 ± 16 pg/ml in normals and by 169 ± 34 pg/ml in hypertensives (mean ± s.e. mean). 2 In the subjects with borderline hypertension isoprenaline infusions were repeated after 7 days of treatment with (±)propranolol (320 mg/day, divided into 4 doses) and subsequently after 7 days of treatment with (±)atenolol (100 mg/day) 2-3 h after the morning dose of β-adrenoceptor blocker. The dose-response curve for plasma noradrenaline was shifted to higher doses of isoprenaline by a factor of 4 by atenolol and the heart rate response was similarly shifted. The heart rate response was shifted by a factor of 16 by propranolol, but plasma noradrenaline did not change after isoprenaline under propranolol treatment, even when isoprenaline was given at doses high enough to induce increments of heart rate similar to those without β-adrenoceptor blocker treatment. 3 In the subjects with borderline hypertension mean and diastolic intra-arterial pressures fell at the highest dose of isoprenaline by 9 ± 2 and 13 ± 2 mm Hg respectively. These effects were antagonized by propranolol and not by atenolol. 4 The observed rise in plasma noradrenaline after isoprenaline might have been caused by baro-reflex-stimulation of central sympathetic outflow. The isoprenaline-induced decrease in mean arterial pressure, however, was small. Moreover pulse pressure rose and this tends to suppress rather than stimulate baroreflex-mediated sympathetic activity. Activation of presynaptic β-adrenoceptors, allegedly of the β2-subtype, is known to facilitate noradrenaline release upon nerve stimulation of isolated tissues. Our results lend support to the hypothesis that such a facilitatory mechanism is also operative in intact man.

[1]  L. Tung,et al.  Adrenaline-induced hypertension in rats. , 1981, Clinical science.

[2]  R. Rizza,et al.  Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. , 1980, Metabolism: clinical and experimental.

[3]  P. Cryer,et al.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.

[4]  D. F. Story,et al.  ADRENALINE ACTIVATION OF PREJUNCTIONAL β‐ADRENOCEPTORS IN GUINEA‐PIG ATRIA , 1980 .

[5]  J. Reid,et al.  Changes in Plasma Norepinephrine, Blood Pressure and Heart Rate During Physical Activity in Hypertensive Man , 1979, Hypertension.

[6]  G. Parati,et al.  Plasma catecholamines and blood pressure responses to the carotid baroreceptor reflex in essential hypertension. , 1979, Clinical science.

[7]  K. Rahn,et al.  Studies on the effects of propranolol on plasma catecholamine levels in patients with essential hypertension , 1978 .

[8]  P. Cryer,et al.  Norepinephrine: hormone and neurotransmitter in man. , 1978, The American journal of physiology.

[9]  P Meyer,et al.  Increased plasma adrenaline concentrations in benign essential hypertension. , 1977, British medical journal.

[10]  S. Z. Langer.  SIXTH GADDUM MEMORIAL LECTURE NATIONAL INSTITUTE FOR MEDICAL RESEARCH, MILL HILL, JANUARY 1977 , 1977, British journal of pharmacology.

[11]  R. Nadeau,et al.  Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors. , 1977, Circulation research.

[12]  S. Langer,et al.  PRESYNAPTIC RECEPTORS AND THEIR ROLE IN THE REGULATION OF TRANSMITTER RELEASE. , 1977 .

[13]  K. Starke.  Regulation of noradrenaline release by presynaptic receptor systems. , 1977, Reviews of physiology, biochemistry and pharmacology.

[14]  J. de Champlain,et al.  The role of the sympathetic system in experimental and human hypertension. , 1977, Postgraduate medical journal.

[15]  I. Kopin,et al.  Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. , 1976, Life sciences.

[16]  L. Stjärne,et al.  Beta2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. , 1976, Acta physiologica Scandinavica.

[17]  J. de Champlain,et al.  Circulating Catecholamine Levels in Human and Experimental Hypertension , 1976, Circulation research.

[18]  J. Brundin,et al.  Dual Adrenoceptor‐mediated Control of Noradrenaline Secretion from Human Vasoconstrictor Nerves: Facilitation by β‐receptors and Inhibition by α‐receptors , 1975 .

[19]  D. Johnson,et al.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. , 1975, Life sciences.

[20]  M. Daly,et al.  Comparison of the reflex vasomotor responses to separate and combined stimulation of the carotid sinus and aortic arch baroreceptors by pulsatile and non‐pulsatile pressures in the dog , 1970, The Journal of physiology.